SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is surging as investors react to reports of a new cloud initiative to monetize excess AI compute capacity, shifting sentiment from concerns over runaway capital expenditure toward potential revenue-generating optionality. The community is actively debating whether this signals a strategic pivot into a viable hyperscaler-style business model or reflects underlying inefficiency and overbuilding in the company's AI infrastructure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing sharp volatility as investors digest reports of potential excess compute capacity in the AI ecosystem and broader sector rotation, leading to a significant pullback from recent highs. While some market participants are expressing concern over high-level valuation and short-term news catalysts, a vocal segment of the community remains focused on strong long-term fundamentals, persistent memory shortages, and strategic supply agreements as reasons to treat the decline as an accumulation opportunity.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending as retail traders target the stock for a potential short squeeze, citing its significantly small float and high short interest as key drivers for volatility. The community is actively comparing the setup to past high-profile squeeze plays, fueling intense debate over whether the company's turnaround plan and debt refinancing efforts will fuel a rally or if the bearish sentiment will prevail.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as the community debates its long-term potential as a digital healthcare infrastructure leader, following a strategic partnership with Walmart to integrate virtual services into the retailer's platform. Investors are closely monitoring high short interest and institutional accumulation, with many discussing the stock's potential for a major rerating if management successfully navigates its ongoing turnaround and margin expansion efforts.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by high short interest and technical setups that many retail investors believe could trigger a significant short squeeze. Market participants are actively discussing the stock's potential for a reversal while closely monitoring enterprise adoption, upcoming earnings, and potential acquisition speculation as key catalysts for future price momentum.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is trending as retail and institutional investors navigate extreme volatility driven by Samsung union strike threats and aggressive rebalancing by the South Korean National Pension Service. The community is actively debating whether these sharp pullbacks represent a structural end to the memory chip rally or merely an artificial discount buying opportunity for a sector expected to face supply shortages through 2028.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest the launch of its proprietary prediction exchange, DKeX, while weighing the competitive implications of Meta's entry into the prediction market space. Community discussion is sharply divided between bulls highlighting record-breaking World Cup betting handle and institutional backing, and bears expressing frustration over stagnant price action and competitive saturation.

General Mills, Inc. engages in the manufacture of food. Its portfolio of brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending after slashing its fiscal 2026 outlook due to weaker-than-expected consumer demand, which triggered a significant sell-off in the stock and dragged down the broader consumer staples sector. Community sentiment is deeply divided between long-term investors viewing the pullback as a generational buying opportunity for a dividend-paying blue chip and traders concerned that inflationary pressures, shifting consumer preferences toward private-label goods, and ongoing margin headwinds could signal further downside.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is experiencing significant volatility driven by institutional interest in nuclear power as a long-term solution to AI-driven electricity demands. While the stock has faced downward pressure from a secondary share offering and sector-wide de-risking, community sentiment remains largely bullish, focusing on its massive nuclear fleet, recent long-term power agreements, and its critical role in the expanding AI infrastructure bottleneck.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is facing significant investor frustration as shareholders debate the company's sluggish performance relative to the broader biotech sector and demand clarity regarding management's long-term strategy. The community is actively discussing the lack of immediate catalysts despite recent aggressive share accumulation by CEO Kevin Tang, leading to widespread speculation about potential M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Pharmaceutical Stocks To Follow Now - February 27th

Eli Lilly and Company, Novo Nordisk A/S, AbbVie, Abbott Laboratories, Gilead Sciences, Pfizer, and Ventyx Biosciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...

Ventyx Biosciences (NASDAQ:VTYX) Sees Unusually-High Trading Volume - Here's What Happened

Ventyx Biosciences (NASDAQ:VTYX) Sees Unusually-High Trading Volume - What's Next...

242,229 Shares in Ventyx Biosciences, Inc. $VTYX Acquired by GSA Capital Partners LLP

GSA Capital Partners LLP acquired a new position in shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX - Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The...

Monaco Asset Management SAM Sells 536,288 Shares of Ventyx Biosciences, Inc. $VTYX

Monaco Asset Management SAM lessened its holdings in shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX - Free Report) by 70.4% in the third quarter, according to its most recent 13F filing with the...

Ventyx Biosciences, Inc. $VTYX Shares Sold by Cibc World Market Inc.

Cibc World Market Inc. reduced its position in Ventyx Biosciences, Inc. (NASDAQ:VTYX - Free Report) by 39.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...

Ventyx Biosciences (VTYX) to Release Earnings on Thursday

Ventyx Biosciences (NASDAQ:VTYX) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Recommendation of "Reduce" from Brokerages

Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX - Get Free Report) have earned a consensus recommendation of "Reduce" from the nine analysts that are covering the stock, Marketbeat.com reports. One...

Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Ventyx Biosciences, Inc. (NasdaqGS: VTYX) to...

Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance

LLY beats Q4 earnings and sales estimates as Mounjaro and Zepbound surge. Shares jump on stronger-than-expected revenue and EPS outlook for 2026.

Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages NATH, VTYX, SKYT Shareholders to Contact the Firm to Discuss Their...

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Nasdaq, S&P 500 Futures Dip As Investors Brace For Jobs Data, Tariff Ruling: Why NVDA, MSFT, AAPL, APLD, NIO Are On Traders' Radar Today

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.51	--	--	N/A
Q4 '25	-$0.44	--	--	N/A
Q3 '25	-$0.45	-$0.32	28.69%	BEAT
Q2 '25	-$0.47	-$0.38	19.15%	BEAT
Q1 '25	-$0.48	-$0.39	19.47%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

VTYXVentyx Biosciences Inc

Latest Earnings Results: Q4 '25

Historical Earnings

Latest VTYX News